REQUEST A DEMO
Total
USD $0.00
Search more companies

Glenmark Pharmaceuticals S.R.O. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Glenmark Pharmaceuticals S.R.O. Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Glenmark Pharmaceuticals S.R.O. is an enterprise in Czech Republic, with the main office in Prague. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 06, 1992. Glenmark Pharmaceuticals S.R.O. currently employs 200 - 249 (2024) people. In 2023, Glenmark Pharmaceuticals S.R.O.’s net profit margin decreased by 0.14%.

Headquarters
Hvezdova 1716/2
Prague; The City of Prague; Postal Code: 14000

Contact Details: Purchase the Glenmark Pharmaceuticals S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Glenmark Pharmaceuticals S.R.O. report to view the information.
Outstanding Shares:
Purchase the Glenmark Pharmaceuticals S.R.O. report to view the information.
Registered Capital:
Purchase the Glenmark Pharmaceuticals S.R.O. report to view the information.
Incorporation Date:
May 06, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glenmark Pharmaceuticals S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
6.46%
Operating Profit Margin (ROS)
-0.17%
Net Profit Margin
-0.14%
Return on Equity (ROE)
-0.35%
Cash Ratio
-100%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?